← Explorer/Network

Melittin inhibits tumor cell migration and enhances cisplatin sensitivity by suppressing IL‐17 signaling pathway gene LCN2 in castration‐resistant prostate cancer

Rucheng Yan, Weiwei Dai, Yuanshen Mao +4 more2023The ProstateJournal Article
10.1002/pros.24605PubMed

Abstract

In brief, our study indicates that LCN2 plays an oncogenic role in CRPC and melittin may be selected as an attractive candidate for CRPC therapy.

References (1)

  • Chronic biotoxin-associated illness: Multiple-system symptoms, a vision deficit, and effective treatmentNeurotoxicology and Teratology · 2005